Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Onsdag 28 Oktober | 21:08:55 Europe / Stockholm

Svenska | English

Investor Relations

Public Relations

Redeye

Bifogade filer

Redeye Initiates Coverage of Lipum

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Redeye Initiates Coverage of Lipum

2022-06-01 10:00:00

Redeye initiates coverage of Lipum, a Swedish biotech company offering a unique approach to the USD 60 billion-plus inflammatory diseases market. Lipum is establishing a unique platform which will be the key driver for continued development and long-term growth. With lead candidate, SOL-116, now entering the clinic, we argue it has the potential to mark a new era in rheumatoid arthritis (RA). Should it manage to deliver encouraging clinical data, it could catch the eye of large industry players.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/